231 related articles for article (PubMed ID: 21529178)
1. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.
Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ
Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178
[TBL] [Abstract][Full Text] [Related]
2. Current standing and frontiers of gene therapy for meningiomas.
De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E
Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129
[TBL] [Abstract][Full Text] [Related]
3. New prospects for management and treatment of inoperable and recurrent skull base meningiomas.
Johnson MD; Sade B; Milano MT; Lee JH; Toms SA
J Neurooncol; 2008 Jan; 86(1):109-22. PubMed ID: 17624496
[TBL] [Abstract][Full Text] [Related]
4. Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
Peyre M; Feuvret L; Sanson M; Navarro S; Boch AL; Loiseau H; Kalamarides M
J Neurooncol; 2017 Jul; 133(3):633-639. PubMed ID: 28536991
[TBL] [Abstract][Full Text] [Related]
5. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of meningiomas: from basic research to potential clinical applications.
Simon M; Boström JP; Hartmann C
Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
[TBL] [Abstract][Full Text] [Related]
7. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
8. Clear cell meningiomas: three case reports with genetic characterization and review of the literature.
Ohba S; Sasaki H; Kimura T; Ikeda E; Kawase T
Neurosurgery; 2010 Sep; 67(3):E870-1; discussion E871. PubMed ID: 20683214
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.
Iwami K; Natsume A; Ohno M; Ikeda H; Mineno J; Nukaya I; Okamoto S; Fujiwara H; Yasukawa M; Shiku H; Wakabayashi T
Neuro Oncol; 2013 Jun; 15(6):747-58. PubMed ID: 23460320
[TBL] [Abstract][Full Text] [Related]
10. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
11. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
12. A review of epigenetic and gene expression alterations associated with intracranial meningiomas.
He S; Pham MH; Pease M; Zada G; Giannotta SL; Wang K; Mack WJ
Neurosurg Focus; 2013 Dec; 35(6):E5. PubMed ID: 24289130
[TBL] [Abstract][Full Text] [Related]
13. Proteins involved in regulating bone invasion in skull base meningiomas.
Salehi F; Jalali S; Alkins R; Lee JI; Lwu S; Burrell K; Gentili F; Croul S; Zadeh G
Acta Neurochir (Wien); 2013 Mar; 155(3):421-7. PubMed ID: 23238945
[TBL] [Abstract][Full Text] [Related]
14. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
16. Meningioma: an update.
Lusis E; Gutmann DH
Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of intracranial meningiomas.
Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
[TBL] [Abstract][Full Text] [Related]
18. Expression of the JAK and STAT superfamilies in human meningiomas.
Magrassi L; De-Fraja C; Conti L; Butti G; Infuso L; Govoni S; Cattaneo E
J Neurosurg; 1999 Sep; 91(3):440-6. PubMed ID: 10470819
[TBL] [Abstract][Full Text] [Related]
19. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
Murnyák B; Csonka T; Hortobágyi T
Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
[TBL] [Abstract][Full Text] [Related]
20. NF2 status of meningiomas is associated with tumour localization and histology.
Kros J; de Greve K; van Tilborg A; Hop W; Pieterman H; Avezaat C; Lekanne Dit Deprez R; Zwarthoff E
J Pathol; 2001 Jul; 194(3):367-72. PubMed ID: 11439370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
